SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMRN: Amarin Corporation plc
AMRN 13.70+0.3%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Miljenko Zuanic2/13/2012 10:47:51 AM
  Read Replies (1) of 49
 
RE AMRN
RE: Dew D.

Just as curiosity I visited iHub, this is his (DD) latest “crystals” on Stupidity, where I do not see any limitation (on his part):



https://www.siliconinvestor.com/nfvda/boards/read_msg.aspx?message_id=72032228



<<AMRN—Insofar as NDA’s with a new MoA generally go to an advisory panel as a matter of FDA policy, the lack of a panel for AMR101 is somewhat bearish for obtaining NCE status, IMO.



Oh yes, FDA needs input from cardiologist on what should be NCE!



GOOD BLESS AMERICA, and those who leave in it!



PS: Another one is on Orange Book and antibiotic’s patents!
No limitation at all! Not at all!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext